EAM
AERI

Erste Asset Management’s Aerie Pharmaceuticals AERI Stock Holding History

Erste Asset Management’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-14,300
Closed -$415K – 455
2019
Q2 		$415K Hold
14,300
– – 0.02% 329
2019
Q1 		$648K Hold
14,300
– – 0.04% 286
2018
Q4 		$511K Buy
+14,300
New +$671K 0.03% 308

Other funds holding AERI

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

Erste Asset Management's AERI Position: Q3 2019 in Review

Erste Asset Management sold out of Aerie Pharmaceuticals (AERI) in Q3 2019, closing a stake of 14,300 shares — an estimated $415K sold.

Erste Asset Management first reported a position in AERI in Q4 2018 and held it in 3 quarters. The position peaked at $648K in Q1 2019. 167 funds tracked by Wall St. Rank hold AERI as of Q3 2019.

  • Erste Asset Management reported no remaining Aerie Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Erste Asset Management sold 14,300 Aerie Pharmaceuticals shares in Q3 2019, an estimated $415K.
  • Erste Asset Management first reported a position in Aerie Pharmaceuticals in Q4 2018 and held it in 3 quarters.
  • Erste Asset Management's Aerie Pharmaceuticals position peaked at $648K in Q1 2019.
  • 167 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q3 2019.

Based on Erste Asset Management's 13F filing for Q3 2019, filed 22 Nov 2024.